Mitchell Kapoor
Stock Analyst at HC Wainwright & Co.
(3.93)
# 516
Out of 5,172 analysts
336
Total ratings
42.07%
Success rate
12.69%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRSP CRISPR Therapeutics AG | Maintains: Buy | $65 → $80 | $46.24 | +73.01% | 5 | Aug 7, 2025 | |
| HALO Halozyme Therapeutics | Maintains: Buy | $72 → $75 | $63.43 | +18.24% | 37 | Aug 6, 2025 | |
| IONS Ionis Pharmaceuticals | Maintains: Buy | $50 → $65 | $70.99 | -8.44% | 5 | Jul 31, 2025 | |
| ALMS Alumis | Reiterates: Buy | $14 | $25.06 | -44.13% | 13 | Jul 25, 2025 | |
| KRRO Korro Bio | Reiterates: Buy | $100 | $10.75 | +830.23% | 13 | Jul 24, 2025 | |
| ORKA Oruka Therapeutics | Reiterates: Buy | $45 | $38.91 | +15.65% | 6 | Jul 23, 2025 | |
| LEGN Legend Biotech | Reiterates: Buy | $75 | $17.41 | +330.79% | 39 | Jul 17, 2025 | |
| TYRA Tyra Biosciences | Reiterates: Buy | $30 | $37.15 | -19.25% | 20 | Jul 1, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $44 | $15.51 | +183.69% | 14 | Jul 1, 2025 | |
| SRPT Sarepta Therapeutics | Downgrades: Sell | $40 → $10 | $16.69 | -40.08% | 16 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $1 → $10 | $19.12 | -47.70% | 13 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $12.84 | +133.64% | 4 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $125 | $8.52 | +1,367.14% | 17 | Jun 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $15 | $13.42 | +11.77% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $1.19 | +320.17% | 1 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $4 → $5 | $7.94 | -37.03% | 7 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $4.45 | +12.36% | 10 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $15 | $5.65 | +165.49% | 8 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $19.05 | +136.22% | 15 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $2.34 | +28.21% | 1 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $6.51 | +514.44% | 17 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $8.87 | - | 20 | Apr 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $7 | $1.42 | +392.96% | 9 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $5 → $3 | $5.50 | -45.45% | 6 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $2 | $2.42 | -17.36% | 16 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.13 | +696.46% | 15 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $4.45 | +237.08% | 2 | Mar 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36,160,000 → $13,786,000 | $1.30 | +1,060,461,438.46% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $3.03 | - | 4 | Jun 2, 2023 |
CRISPR Therapeutics AG
Aug 7, 2025
Maintains: Buy
Price Target: $65 → $80
Current: $46.24
Upside: +73.01%
Halozyme Therapeutics
Aug 6, 2025
Maintains: Buy
Price Target: $72 → $75
Current: $63.43
Upside: +18.24%
Ionis Pharmaceuticals
Jul 31, 2025
Maintains: Buy
Price Target: $50 → $65
Current: $70.99
Upside: -8.44%
Alumis
Jul 25, 2025
Reiterates: Buy
Price Target: $14
Current: $25.06
Upside: -44.13%
Korro Bio
Jul 24, 2025
Reiterates: Buy
Price Target: $100
Current: $10.75
Upside: +830.23%
Oruka Therapeutics
Jul 23, 2025
Reiterates: Buy
Price Target: $45
Current: $38.91
Upside: +15.65%
Legend Biotech
Jul 17, 2025
Reiterates: Buy
Price Target: $75
Current: $17.41
Upside: +330.79%
Tyra Biosciences
Jul 1, 2025
Reiterates: Buy
Price Target: $30
Current: $37.15
Upside: -19.25%
Summit Therapeutics
Jul 1, 2025
Reiterates: Buy
Price Target: $44
Current: $15.51
Upside: +183.69%
Sarepta Therapeutics
Jun 25, 2025
Downgrades: Sell
Price Target: $40 → $10
Current: $16.69
Upside: -40.08%
Jun 24, 2025
Maintains: Neutral
Price Target: $1 → $10
Current: $19.12
Upside: -47.70%
Jun 16, 2025
Reiterates: Buy
Price Target: $30
Current: $12.84
Upside: +133.64%
Jun 5, 2025
Reiterates: Buy
Price Target: $125
Current: $8.52
Upside: +1,367.14%
Jun 2, 2025
Assumes: Buy
Price Target: $15
Current: $13.42
Upside: +11.77%
Jun 2, 2025
Initiates: Buy
Price Target: $5
Current: $1.19
Upside: +320.17%
May 27, 2025
Upgrades: Buy
Price Target: $4 → $5
Current: $7.94
Upside: -37.03%
May 20, 2025
Reiterates: Buy
Price Target: $5
Current: $4.45
Upside: +12.36%
May 16, 2025
Maintains: Buy
Price Target: $23 → $15
Current: $5.65
Upside: +165.49%
May 13, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $19.05
Upside: +136.22%
Apr 28, 2025
Initiates: Buy
Price Target: $3
Current: $2.34
Upside: +28.21%
Apr 9, 2025
Reiterates: Buy
Price Target: $40
Current: $6.51
Upside: +514.44%
Apr 9, 2025
Downgrades: Neutral
Price Target: n/a
Current: $8.87
Upside: -
Apr 3, 2025
Maintains: Buy
Price Target: $14 → $7
Current: $1.42
Upside: +392.96%
Apr 3, 2025
Maintains: Neutral
Price Target: $5 → $3
Current: $5.50
Upside: -45.45%
Apr 3, 2025
Maintains: Buy
Price Target: $5 → $2
Current: $2.42
Upside: -17.36%
Apr 3, 2025
Reiterates: Buy
Price Target: $9
Current: $1.13
Upside: +696.46%
Mar 24, 2025
Reiterates: Buy
Price Target: $15
Current: $4.45
Upside: +237.08%
Sep 6, 2023
Maintains: Buy
Price Target: $36,160,000 → $13,786,000
Current: $1.30
Upside: +1,060,461,438.46%
Jun 2, 2023
Reiterates: Neutral
Price Target: n/a
Current: $3.03
Upside: -